ALSE Insider Trading Activity and SEC Form 4 Filings
ALSE insider trading summary
No open-market insider purchases or sales of Alseres Pharmaceuticals Inc (ALSE) have been reported on SEC Form 4 in the past 12 months.
Latest ALSE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 9, 2009 | Robert L Gipson | 10% Owner | Buy | $1.0M (1,456,522 @ $0.69) |
| Nov 20, 2008 | Robert L Gipson | 10% Owner | Buy | $1000K (543,478 @ $1.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.